TGF-&bgr;/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation
AUTOR(ES)
Fiocchi, Claudio
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=209413Documentos Relacionados
- Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
- TLP, a novel modulator of TGF-β signaling, has opposite effects on Smad2- and Smad3-dependent signaling
- Migraine and cardiovascular disease: Possible mechanisms of interaction
- Chronic granulomatous disease: why an inflammatory disease?
- Pathological mimics of chronic inflammatory bowel disease.
